Identification of cell-free microRNAs in the urine of patients with prostate cancer

Current methods for the early detection of prostate cancer (PCa), in particular prostate-specific antigen screening, are likely to benefit from complementary molecular analyses to enhance specificity. MicroRNAs (miRNA) are small endogenously expressed noncoding RNAs that negatively regulate the expr...

Full description

Saved in:
Bibliographic Details
Main Authors: Korzeniewski, Nina (Author) , Tosev, Georgi (Author) , Pahernik, Sascha (Author) , Hadaschik, Boris (Author) , Hohenfellner, Markus (Author) , Duensing, Stefan (Author)
Format: Article (Journal)
Language:English
Published: 2015
In: Urologic oncology
Year: 2014, Volume: 33, Issue: 1, Pages: 16.e17-16.e22
ISSN:1873-2496
DOI:10.1016/j.urolonc.2014.09.015
Online Access:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.urolonc.2014.09.015
Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S1078143914003354
Get full text
Author Notes:Nina Korzeniewski, Georgi Tosev, Sascha Pahernik, Boris Hadaschik, Markus Hohenfellner, Stefan Duensing
Description
Summary:Current methods for the early detection of prostate cancer (PCa), in particular prostate-specific antigen screening, are likely to benefit from complementary molecular analyses to enhance specificity. MicroRNAs (miRNA) are small endogenously expressed noncoding RNAs that negatively regulate the expression of protein-coding genes at the transcriptional or translational level. Accumulating evidence suggests that miRNAs play an important role in tumorigenesis, are differentially expressed in different cancer types, and can be found in all bodily fluids so-far tested, including urine.
Item Description:Available online 23 October 2014
Gesehen am 22.07.2020
Physical Description:Online Resource
ISSN:1873-2496
DOI:10.1016/j.urolonc.2014.09.015